Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Biology of prostate-specific antigen
SP Balk, YJ Ko, GJ Bubley - Journal of clinical oncology, 2003 - ascopubs.org
Prostate-specific antigen (PSA) is an androgen-regulated serine protease produced by both
prostate epithelial cells and prostate cancer (PCa) and is the most commonly used serum …
prostate epithelial cells and prostate cancer (PCa) and is the most commonly used serum …
Screening for prostate cancer
Background Any form of screening aims to reduce disease‐specific and overall mortality,
and to improve a person's future quality of life. Screening for prostate cancer has generated …
and to improve a person's future quality of life. Screening for prostate cancer has generated …
Mathematical model-driven deep learning enables personalized adaptive therapy
Standard-of-care treatment regimens have long been designed for maximal cell killing, yet
these strategies often fail when applied to metastatic cancers due to the emergence of drug …
these strategies often fail when applied to metastatic cancers due to the emergence of drug …
Current status of biomarkers for prostate cancer
VM Velonas, HH Woo, CG dos Remedios… - International journal of …, 2013 - mdpi.com
Prostate cancer (PCa) is a leading cause of cancer-related death of men globally. Since its
introduction, there has been intense debate as to the effectiveness of the prostate specific …
introduction, there has been intense debate as to the effectiveness of the prostate specific …
A review on the clinical utility of PSA in cancer prostate
M Adhyam, AK Gupta - Indian journal of surgical oncology, 2012 - Springer
Prostate cancer has come to share the oncological centrestage among male cancers. The
availability of Serum Prostate Specific Antigen, PSA, as a marker has encouraged it's use to …
availability of Serum Prostate Specific Antigen, PSA, as a marker has encouraged it's use to …
Screening for prostate cancer: an update of the evidence for the US Preventive Services Task Force
Background: In US men, prostate cancer is the most common noncutaneous cancer and the
second leading cause of cancer death. Screening for prostate cancer is controversial …
second leading cause of cancer death. Screening for prostate cancer is controversial …
Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis
OBJECTIVE:: Measurement of serum prostate-specific antigen (PSA) for the detection of
prostate cancer has poor specificity in men with PSA levels between 2 and 10ng/ml. It has …
prostate cancer has poor specificity in men with PSA levels between 2 and 10ng/ml. It has …
[PDF][PDF] Prostate testing for cancer and treatment (ProtecT) feasibility study
Background There is currently insufficient evidence to introduce population screening for
prostate cancer. While it is accepted that prostate cancer is an important public health …
prostate cancer. While it is accepted that prostate cancer is an important public health …
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer
Prostate cancer (PCa) is the most common male cancer in the United States. A major
challenge that remains is to predict the clinical outcome in managing PCa patients. The …
challenge that remains is to predict the clinical outcome in managing PCa patients. The …
Prostate biopsy: indications and technique
BR Matlaga, LA Eskew… - The Journal of urology, 2003 - auajournals.org
Purpose: The last decade has seen numerous modifications in the way prostate cancer is
diagnosed. We review the current indications for and methods of prostate biopsy. Materials …
diagnosed. We review the current indications for and methods of prostate biopsy. Materials …